German contract development and manufacturing organization Vetter launched construction of a $285 million clinical manufacturing site in Des Plaines, Illinois, expanding aseptic drug production and supporting specialized early development injectables. The 160,000-square-foot facility expected by 2029 enhances capacity for clinical operations alongside their Austrian site. This reflects continued investment to meet growing biopharma demands for low-volume clinical-grade manufacturing in the U.S. market.